Letter to the Editor: Proposal for Th1-Induction Therapy for Atopic Dermatitis: A Possibility for the Use of the Varicella Zoster Virus Vaccine

Abstract

Get full access to this article

View all access options for this article.

References

Fujimura

, Yamanashi

, Masuzawa

, et al. Conversion of the CD4+ T cell profile from T(H2)-dominant type to T(H1)-dominant type after varicella-zoster virus infection in atopic dermatitis. J Allergy Clin Immunol, 1997; 100:274–282.

Horiuchi

. Th1 regulatory events by infectious pathogens, herpes zoster and herpes simplex viruses: Prospects for therapeutic options for atopic eczema. Adv Dematol Allog, 2022; 39:662–667.

Katsunuma

, Kawahara

, Yuki

, et al. Impaired interferon-gamma production in a subset population of severe atopic dermatitis. Int Arch Allergy Immunol, 2004; 134:240–247.

Kim

, Kim

, Leung

DYM

. Pathophysiology of atopic dermatitis: Clinical implications. Allergy Asthma Proc, 2019; 40:84–92.

Levin

, Weinberg

. Immune responses to zoster vaccines. Hum Vaccin Immunother, 2019; 15:772–777.

Zerboni

, Sen

, Stefan

, et al. Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol, 2014; 12:197–210.